Recommendations on the EAEU Marketing Authorisation Procedures to Optimise the Performance of Regulatory Affairs Specialists
Since 2021, the marketing authorisation (MA) of new medicinal products in the Russian Federation has been carried out according to the Rules of Marketing Authorisation and Assessment of Medicinal Products for Human Use that are implemented by Decision No. 78 of the Council of the Eurasian Economic C...
Saved in:
Main Authors: | E. M. Rychikhina, O. G. Tkachenko, V. V. Kosenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)
2023-07-01
|
Series: | Регуляторные исследования и экспертиза лекарственных средств |
Subjects: | |
Online Access: | https://www.vedomostincesmp.ru/jour/article/view/544 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preparation of Module 1 of the Registration Dossier According to the EAEU Procedure
by: E. M. Rychikhina
Published: (2022-10-01) -
Mutual Recognition Procedure for the Registration of Medicines: New Challenges or Opportunities
by: A. V. Foteeva, et al.
Published: (2022-02-01) -
Submission of Documents on the Pharmacovigilance System as Part of the Registration Dossier within the Framework of the EAEU Procedures: Analysis of Requirements and Typical Errors
by: N. Yu. Velts, et al.
Published: (2024-10-01) -
On the Issue of the Effectiveness of the Department for Registration of Medicines
by: A. V. Foteeva, et al.
Published: (2022-12-01) -
Editorial Note
by: Virginia Paola Forace
Published: (2025-07-01)